All AbMole products are for research use only, cannot be used for human consumption.
Etrumadenant (AB928, A2aR/A2bR antagonist-1) is an orally bioavailable, dual antagonist of the A2aR and A2bR adenosine receptors, with Kd of 1.4 nM and 2 nM for A2aR and A2bR, respectively. Etrumadenant leads to greater immunomodulatory activity and reduced tumor growth.
| Molecular Weight | 426.47 |
| Formula | C23H22N8O |
| CAS Number | 2239273-34-6 |
| Solubility (25°C) | DMSO ≥ 60 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Adenosine Receptor Products |
|---|
| SYN115
Tozadenant (SYN115) is a novel, selective adenosine A(2A) receptor antagonist. |
| CGS 21680 hydrochloride
CGS 21680 hydrochloride is an A2A adenosine receptor agonist with an Ki of 27 nM. |
| Istradefylline
Istradefylline (KW-6002) is a potent, selective and orally active adenosine A2A receptor (A2AR) antagonist with Ki of 2.2 nM. |
| CGS 21680
CGS 21680 is a selective adenosine receptor agonist for A2A and A3 with Ki of 15 ng/mL and 37 ng/mL, respectively. |
| Norisoboldine
Norisoboldine is an isoquinoline alkaloid which acts as an AhR agonist. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
